Get the Stockscreener App
19.36
1.02%
-0.20
After Hours:
19.36
Apollomics Inc stock is traded at $19.36, with a volume of 12,617.
It is down -1.02% in the last 24 hours and up +38.29% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
See More
Previous Close:
$19.56
Open:
$19.36
24h Volume:
12,617
Relative Volume:
1.12
Market Cap:
$42.52M
Revenue:
$8.50M
Net Income/Loss:
$-10.94M
P/E Ratio:
-2.5575
EPS:
-7.57
Net Cash Flow:
$-28.76M
1W Performance:
-8.85%
1M Performance:
+38.29%
6M Performance:
-4.40%
1Y Performance:
+215.31%
1-Day Range:
$18.88
$19.60
1-Week Range:
$18.25
$22.00
52-Week Range:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
19.36 | 46.03M | 8.50M | -10.94M | -28.76M | -7.57 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apollomics Inc Stock (APLM) Latest News
Apollomics Inc. Warrant 2023-01.04.28 on Apollomics Financial Disclosures & SEC Filings - TradingView
Apollomics Company Profile & Introduction - Moomoo
Number of shareholders of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to revenue forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to EBIT forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Price to book forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Price to earnings forward of Apollomics Inc. – NASDAQ:APLM - TradingView
Enterprise value to EBITDA forward of Apollomics Inc. – BOATS:APLM - TradingView
APLM Forecast — Price Target — Prediction for 2027 - TradingView
Apollomics Inc. Class A Actuals & Estimates (BOATS:APLM) - TradingView
Apollomics Inc (APLM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apollomics Warrant (APLMW) Inches Upward Amidst Sluggish Trading at $0.01Thematic ETF Flow - dars.gov.et
Apollomics Terminates License Agreement With Launxp International - Moomoo
Nasdaq flags Apollomics (NASDAQ: APLM) as MVLS falls short and Launxp deal ends - Stock Titan
Apollomics Receives Nasdaq Deficiency Notice Regarding - GlobeNewswire
Apollomics Inc (APLMW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apollomics Inc (APLM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Discipline and Rules-Based Execution in APLM Response - Stock Traders Daily
Apollomics Inc (APLMW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apollomics Inc (APLMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apollomics Inc (APLMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics Inc (APLM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Apollomics Inc (APLM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics (APLM) CFO RSU vesting triggers 3,588-share tax withholding - Stock Titan
Apollomics Inc (APLM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apollomics Inc (APLM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apollomics Inc (APLM) Institutional Confidence - TradingKey
Apollomics Inc (APLM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apollomics (APLM) CEO Hung-Wen Chen gains 5,000 shares as RSUs vest - Stock Titan
Apollomics (APLM) director acquires 500 shares through RSU vesting - Stock Titan
Apollomics (APLM) director vests 500 RSUs into Class A shares - Stock Titan
Apollomics (APLM) director receives 500 shares from RSU vesting - Stock Titan
[Form 4] Apollomics Inc. Insider Trading Activity - Stock Titan
Director at Apollomics (APLM) gains 500 shares from vested RSUs - Stock Titan
Apollomics Inc (APLMW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apollomics Inc (APLMW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apollomics Inc. (APLM) Faces Pressure Amid Recent Decline – Key Levels to WatchBearish Pattern Stocks - newsline.com
Behavioral Patterns of APLM and Institutional Flows - Stock Traders Daily
[EFFECT] Apollomics Inc. SEC Filing - Stock Titan
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Apollomics Inc. (APLM) Edges Higher as Stock Tests Resistance Near $14.86Volume Profile - The Legal Advocate
(APLM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Apollomics Inc. Warrant (APLMW) Trades Flat at $0.01 Amid Minimal ActivityLow Volatility Picks - newsline.com
Apollomics Inc. Warrant (APLMW) Stalls at $0.01: Micro-Cap Warrant Holds Steady Amid Minimal Trading ActivitySmart Beta Flow - The Legal Advocate
Apollomics Inc. Warrant (APLMW) Holds Steady Near Minimal Levels – A Closer Look at the Biotech DerivativeCup and Handle - The Legal Advocate
Apollomics Warrants (APLMW) Hold at $0.01 After Modest Gain – Tight Trading Range PersistsCommunity Buy Alerts - Newser
APLMW Technical Analysis | Trend, Signals & Chart Patterns | APOLLOMICS INC-27 (NASDAQ:APLMW) - ChartMill
Apollomics Inc. (APLMW) Warrants Trade at $0.01 After Double-Digit DeclineSell Signal Alerts - Newser
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Apollomics Inc Stock (APLM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chen Hung-Wen | Chief Executive Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
5,000 |
0 |
148,334 |
| CHU YI-AN | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| CHEN HONG-JUNG | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
3,620 |
| TSAI HSIEN-SHU | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| Chen Yi-Kuei | Chief Operating Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
5,000 |
0 |
15,000 |
| Jan Chen-Huan | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,500 |
| Huang Ya-Chi | Director |
May 17 '26 |
Option Exercise |
0.00 |
500 |
0 |
1,000 |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):